2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1215967740 MD
Verify on CMS →

DEBRA GUTHRIE, MD

Glaucoma Specialist (Ophthalmology) Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
754
Medicare Part D claims · 193 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.2532/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$570.38
29 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DEBRA GUTHRIE, MD reported a CMS MIPS final score of 91.2532/100 — above the 83.1 national average — and filed 754 Medicare Part D claims in 2023.

91.2532/100
MIPS score · +8 vs avg
754
Part D claims, 2023
41%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEBRA GUTHRIE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

DEBRA GUTHRIE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DEBRA GUTHRIE, MD?

High performer (top quartile)

NPI registry status

Active

Issued 07/03/2006

NPI 1215967740

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

754 75% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

91.2532/100 8.153200000000012% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among New York providers

New York providers

Glaucoma Specialist (Ophthalmology) Physician share within New York

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within New York

Medicare quality performance — MIPS

DEBRA GUTHRIE, MD's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
91.2532/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 91.2532/100 vs national avg 83.1

0%100%National avg83%91.3%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 91.2532/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBRA GUTHRIE, MD is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1215967740. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DEBRA GUTHRIE, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 6 E 39TH ST STE 1103, NEW YORK, NY, 10016, with a listed phone of (212) 685-2600. NPI 1215967740 was issued on 07/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GUTHRIE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 754 prescription claims written by this provider, covering 193 Medicare beneficiaries and totaling roughly $228K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2532/100 for the 2023 performance year (Quality 74.9203), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6 E 39TH ST STE 1103
NEW YORK, NY 10016

Provider Details

NPI 1215967740
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Female
NPI Issued 07/03/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.2532
Final Score
Avg: 83.1
74.9203
Quality
91.6794
Promoting Interoperability

Reporting: Alternative Payment Model

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBRA GUTHRIE, MD. Source: openpaymentsdata.cms.gov.

Total received

$570

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DEBRA GUTHRIE, MD. To verify DEBRA GUTHRIE, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

DEBRA GUTHRIE, MD — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 754 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

754
Total Claims
$228K
Total Drug Cost
193
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,295
Total Day Supply
36,807
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$222K

Patient Demographics

Average Patient Age
77.4 years
Avg HCC Risk Score
0.95
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
202
Lumigan
Bimatoprost
82
Restasis
Cyclosporine
57
Combigan
Brimonidine Tartrate/Timolol
38
Prednisolone Acetate
38
Timolol Maleate
34
Simbrinza
Brinzolamide/Brimonidine Tart
27
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
27
Erythromycin
Erythromycin Base
25
Vyzulta
Latanoprostene Bunod
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How DEBRA GUTHRIE, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

DEBRA GUTHRIE, MD's 754 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GUTHRIE.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBRA GUTHRIE, MD's specialty?
DEBRA GUTHRIE, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in NEW YORK, New York. Credentials: MD.
How much does DEBRA GUTHRIE, MD prescribe under Medicare Part D?
In 2023, DEBRA GUTHRIE, MD wrote 754 Medicare Part D claims totaling $228K in drug costs for 193 beneficiaries.
What is DEBRA GUTHRIE, MD's Medicare quality score?
DEBRA GUTHRIE, MD has a CMS MIPS Final Score of 91.2532/100 (Quality: 74.9203). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DEBRA GUTHRIE, MD located?
DEBRA GUTHRIE, MD is located at 6 E 39TH ST STE 1103, NEW YORK, NY, 10016. Phone: (212) 685-2600.
What is DEBRA GUTHRIE, MD's NPI number?
DEBRA GUTHRIE, MD's National Provider Identifier (NPI) is 1215967740, issued on 07/03/2006.
Does DEBRA GUTHRIE, MD prescribe more brand-name or generic drugs?
DEBRA GUTHRIE, MD's prescribing is 59% brand-name and 41% generic drugs by claim count, with $222K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does DEBRA GUTHRIE, MD prescribe most often?
Based on 2023 Medicare Part D data, DEBRA GUTHRIE, MD's most frequently prescribed drugs include Latanoprost, Lumigan, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBRA GUTHRIE, MD accept Medicare?
DEBRA GUTHRIE, MD appears in CMS Medicare data with 754 Part D claims and 193 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBRA GUTHRIE, MD's credentials?
DEBRA GUTHRIE, MD's NPI is 1215967740 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology